Open Payments

MARY IMOGENE BASSETT HOSPITAL

Type
Teaching hospital
Where
Cooperstown, NY
Medicare CCN
330136
Received
$72,112 in 46 records, 2019 ($18,634 general, $53,478 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2019General payment29$18,634
2019Research payment17$53,478

By company

CompanyRecordsAmountYears
Relievant Medsystems, Inc.2$21,8462019
Akcea Therapeutics, Inc.2$10,4202019
Boehringer Ingelheim Pharmaceuticals, Inc.3$7,8112019
Alnylam Pharmaceuticals Inc.4$7,2632019
Celgene Corporation2$4,7502019
Incyte Corporation5$3,3872019
Sysmex America, Inc.18$2,9772019
Medline Industries LP1$2,5002019
Abbott Laboratories2$2,3002019
AstraZeneca Pharmaceuticals LP1$2,0002019
Medtronic Vascular, Inc.1$2,0002019
Novartis Pharmaceuticals Corporation1$2,0002019
PFIZER INC.1$1,5002019
Chiesi USA, Inc.1$1,2002019
Linvatec Corporation1$1452019
Surgical Specialties Corporation (us), Inc. (dba Corza Medical)1$122019

By nature of payment

NatureRecordsAmount
Research payment17$53,478
Space rental or facility fees (teaching hospital only)8$13,000
Travel and Lodging10$2,712
Charitable Contribution1$2,500
Food and Beverage9$277
Grant1$145

Records

DateCompanyAmountNatureFormProductStudyYear
2019-12-31Linvatec Corporation$145GrantIn-kind items and servicesHALL POWER Device, ORTHOPEDIC SURGERY2019
2019-12-05Alnylam Pharmaceuticals Inc.$2,421Research paymentCash or cash equivalentONPATTRO Drug, Genetic DiseaseThe Study of an Investigational Drug, Patisiran ALN-TTR02, for the Treatment of Transthyretin TTR-Mediated Amyloidosis i2019
2019-11-26Sysmex America, Inc.$409Travel and LodgingCash or cash equivalentXN Series Device, Hematology2019
2019-11-26Sysmex America, Inc.$404Travel and LodgingCash or cash equivalentXN Series Device, Hematology2019
2019-11-26Sysmex America, Inc.$207Travel and LodgingCash or cash equivalentXN Series Device, Hematology2019
2019-11-26Sysmex America, Inc.$202Travel and LodgingCash or cash equivalentXN Series Device, Hematology2019
2019-11-26Sysmex America, Inc.$19Food and BeverageCash or cash equivalentXN Series Device, Hematology2019
2019-11-26Sysmex America, Inc.$19Food and BeverageCash or cash equivalentXN Series Device, Hematology2019
2019-11-25Sysmex America, Inc.$37Food and BeverageCash or cash equivalentXN Series Device, Hematology2019
2019-11-25Sysmex America, Inc.$37Food and BeverageCash or cash equivalentXN Series Device, Hematology2019
2019-11-25Sysmex America, Inc.$37Food and BeverageCash or cash equivalentXN Series Device, Hematology2019
2019-11-25Sysmex America, Inc.$37Food and BeverageCash or cash equivalentXN Series Device, Hematology2019
2019-11-25Sysmex America, Inc.$37Food and BeverageCash or cash equivalentXN Series Device, Hematology2019
2019-11-25Sysmex America, Inc.$37Food and BeverageCash or cash equivalentXN Series Device, Hematology2019
2019-11-23Novartis Pharmaceuticals Corporation$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentENTRESTO Drug, CARDIOVASCULAR2019
2019-11-14Chiesi USA, Inc.$1,200Space rental or facility fees (teaching hospital only)Cash or cash equivalentKENGREAL Drug, CARDIOVASCULAR2019
2019-11-13Abbott Laboratories$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentCardiovascular- Research only Device, Cardiac Arrhythmias and Heart Failure2019
2019-11-06AstraZeneca Pharmaceuticals LP$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentBRILINTA Drug, Cardiovascular and Metabolism2019
2019-10-28PFIZER INC.$1,500Space rental or facility fees (teaching hospital only)Cash or cash equivalentELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE2019
2019-10-28Sysmex America, Inc.$613Travel and LodgingCash or cash equivalentXN Series Device, Hematology2019
2019-10-28Sysmex America, Inc.$416Travel and LodgingCash or cash equivalentXN Series Device, Hematology2019
2019-10-28Sysmex America, Inc.$416Travel and LodgingCash or cash equivalentXN Series Device, Hematology2019
2019-10-28Sysmex America, Inc.$30Travel and LodgingCash or cash equivalentXN Series Device, Hematology2019
2019-10-28Sysmex America, Inc.$6Travel and LodgingCash or cash equivalentXN Series Device, Hematology2019
2019-10-28Sysmex America, Inc.$6Travel and LodgingCash or cash equivalentXN Series Device, Hematology2019
2019-10-25Akcea Therapeutics, Inc.$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentTEGSEDI Drug, NEUROLOGY2019
2019-10-22Medtronic Vascular, Inc.$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentResolute Device, Stents2019
2019-10-09Celgene Corporation$1,500Research paymentCash or cash equivalentRevlimid Drug, Hematology / OncologyConnect Myeloid: The Myelofibrosis (MF), Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Regist2019
2019-10-03Surgical Specialties Corporation (us), Inc. (dba Corza Medical)$12Food and BeverageCash or cash equivalentSurgical wound closure product Medical Supply, Surgical wound closure product2019
2019-09-20Alnylam Pharmaceuticals Inc.$1,452Research paymentCash or cash equivalentONPATTRO Drug, Genetic DiseaseThe Study of an Investigational Drug, Patisiran ALN-TTR02, for the Treatment of Transthyretin TTR-Mediated Amyloidosis i2019
2019-08-09Boehringer Ingelheim Pharmaceuticals, Inc.$175Research paymentIn-kind items and servicesCOPD pragmatic randomised clinical trial2019
2019-07-23Akcea Therapeutics, Inc.$8,420Research paymentCash or cash equivalentISIS 678354-CS22019
2019-06-14Alnylam Pharmaceuticals Inc.$2,421Research paymentCash or cash equivalentONPATTRO Drug, Genetic DiseaseThe Study of an Investigational Drug, Patisiran ALN-TTR02, for the Treatment of Transthyretin TTR-Mediated Amyloidosis i2019
2019-06-10Incyte Corporation$12Research paymentCash or cash equivalentPROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED 2019
2019-06-10Incyte Corporation$10Research paymentCash or cash equivalentPROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED 2019
2019-05-08Incyte Corporation$35Research paymentCash or cash equivalentPROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED 2019
2019-04-29Incyte Corporation$1,890Research paymentCash or cash equivalentPROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED 2019
2019-04-03Abbott Laboratories$300Space rental or facility fees (teaching hospital only)Cash or cash equivalentCardiovascular- Research only Device, Cardiac Arrhythmias and Heart Failure2019
2019-03-04Alnylam Pharmaceuticals Inc.$968Research paymentCash or cash equivalentONPATTRO Drug, Genetic DiseaseThe Study of an Investigational Drug, Patisiran ALN-TTR02, for the Treatment of Transthyretin TTR-Mediated Amyloidosis i2019
2019-02-05Boehringer Ingelheim Pharmaceuticals, Inc.$3,700Research paymentCash or cash equivalentCOPD pragmatic randomised clinical trial2019
2019-02-05Incyte Corporation$1,440Research paymentCash or cash equivalentPROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED 2019
2019-02-01Boehringer Ingelheim Pharmaceuticals, Inc.$3,936Research paymentCash or cash equivalentPRADAXA Drug, CARDIOVASCULARGLORIA AF Registry Phase II III Core2019
2019-01-28Medline Industries LP$2,500Charitable ContributionCash or cash equivalent2019
2019-01-18Celgene Corporation$3,250Research paymentCash or cash equivalentRevlimid Drug, Hematology / OncologyCelgene - Connect MDSAML2019
2019-01-16Relievant Medsystems, Inc.$16,677Research paymentCash or cash equivalentIntracept Device, PainINTRACEPT2019
2019-01-16Relievant Medsystems, Inc.$5,169Research paymentCash or cash equivalentIntracept Device, PainINTRACEPT2019

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

In New York; placed by its state only.

MeasureState
New York
Population B0100319,852,366
Population, 2020 census P120,201,249
Median age B0100239.8
Under 18 B0100120.5%
65 and over B0100117.9%
Households B110017,722,646
Foreign born B0500222.8%
Median household income B19013$85,974
Median family income B19113$106,873
Per capita income B19301$50,712
Poverty rate B1700114.0%
Unemployment rate B230256.4%
Civilian labor force B2302510,171,766
Mean commute (minutes) B0801332.6
Bachelor's degree or higher B1500340.2%
Housing units B250018,585,241
Owner-occupied B2500354.3%
Renters B2500345.7%
Median home value B25077$423,800
Median gross rent B25064$1,621
White, not Hispanic B0300252.8%
Black B0300213.4%
Hispanic or Latino B0300219.8%
Asian B030029.0%
American Indian and Alaska Native B030020.2%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in New York.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.